With the development of genetic testing technologies such as genome-wide association studies (GWAS) and next-generation sequencing (NGS), it has been discovered that approximately 127 locus abnormalities in the human genome are associated with the onset and progression of obesity [4] , as along with more than 550 monogenic mutations related to obesity [5]
Synergistic effects of brain injury and aging: common mechanisms of proteostatic dysfunction
doi: 10.1289/ehp.1307175 7 KortenkampA
Given superior weight loss and comorbidity impact, analysts expect multi-agonists to exceed 45% of the anti-obesity drugs market by 2031
For the majority of the studies, the outcomes were presented graphically, and we used the software WebPlotDigitizer to estimate the values from graphs
Record what you told the patient, why you made your clinical decision, and any referrals you suggested